Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 257

1.

Isolated Right Ventricular Apical Hypoplasia Without Atrial Septal Defect.

Otsuka Y, Sato K, Sueta D, Suzuki S, Matsuo O, Usuku H, Imamura K, Takashio S, Oda S, Arima Y, Sakamoto K, Yamamoto E, Nakamura S, Kawano H, Kaikita K, Tsujita K.

Circ J. 2019 Jan 22. doi: 10.1253/circj.CJ-18-1234. [Epub ahead of print] No abstract available.

2.

Plasminogen activator inhibitor-1 deficiency suppresses osteoblastic differentiation of mesenchymal stem cells in mice.

Takafuji Y, Tatsumi K, Ishida M, Kawao N, Okada K, Matsuo O, Kaji H.

J Cell Physiol. 2019 Jun;234(6):9687-9697. doi: 10.1002/jcp.27655. Epub 2018 Nov 1.

PMID:
30387130
3.

Latent tuberculosis infection and tuberculosis in children and adolescents.

Ishikawa CS, Matsuo OM, Sarno F.

Einstein (Sao Paulo). 2018 Sep 17;16(3):eAO4090. doi: 10.1590/S1679-45082018AO4090. English, Portuguese.

4.

Plasminogen activator inhibitor-1 is involved in interleukin-1β-induced matrix metalloproteinase expression in murine chondrocytes.

Moritake A, Kawao N, Okada K, Ishida M, Tatsumi K, Matsuo O, Akagi M, Kaji H.

Mod Rheumatol. 2018 Nov 28:1-5. doi: 10.1080/14397595.2018.1525018. [Epub ahead of print]

PMID:
30220231
5.

Roles of plasminogen in the alterations in bone marrow hematopoietic stem cells during bone repair.

Okada K, Kawao N, Tatsumi K, Ishida M, Takafuji Y, Kurashimo S, Okumoto K, Kojima K, Matsuo O, Kaji H.

Bone Rep. 2018 Apr 27;8:195-203. doi: 10.1016/j.bonr.2018.04.005. eCollection 2018 Jun.

6.

Role of Macrophages and Plasminogen Activator Inhibitor-1 in Delayed Bone Repair in Diabetic Female Mice.

Shimoide T, Kawao N, Tamura Y, Okada K, Horiuchi Y, Okumoto K, Kurashimo S, Ishida M, Tatsumi K, Matsuo O, Kaji H.

Endocrinology. 2018 Apr 1;159(4):1875-1885. doi: 10.1210/en.2018-00085.

PMID:
29534207
7.

Plasminogen activator inhibitor-1 deficiency enhances subchondral osteopenia after induction of osteoarthritis in mice.

Moritake A, Kawao N, Okada K, Tatsumi K, Ishida M, Okumoto K, Matsuo O, Akagi M, Kaji H.

BMC Musculoskelet Disord. 2017 Sep 11;18(1):392. doi: 10.1186/s12891-017-1752-5.

8.

α2-antiplasmin modulates bone formation by negatively regulating osteoblast differentiation and function.

Kanno Y, Ishisaki A, Kuretake H, Maruyama C, Matsuda A, Matsuo O.

Int J Mol Med. 2017 Sep;40(3):854-858. doi: 10.3892/ijmm.2017.3055. Epub 2017 Jul 5.

PMID:
28677806
9.

A synthetic peptide derived from staphylokinase enhances FGF-2-induced skin wound healing in mice.

Okada K, Kojima K, Okumoto K, Kawao N, Matsuo O, Kaji H.

Thromb Res. 2017 Sep;157:7-8. doi: 10.1016/j.thromres.2017.06.032. Epub 2017 Jun 27. No abstract available.

PMID:
28672125
10.

Role of plasminogen activator inhibitor-1 in glucocorticoid-induced muscle change in mice.

Tamura Y, Kawao N, Shimoide T, Okada K, Matsuo O, Kaji H.

J Bone Miner Metab. 2018 Mar;36(2):148-156. doi: 10.1007/s00774-017-0825-8. Epub 2017 Mar 20.

PMID:
28321652
11.

The blocking of uPAR suppresses lipopolysaccharide-induced inflammatory osteoclastogenesis and the resultant bone loss through attenuation of integrin β3/Akt pathway.

Kanno Y, Ishisaki A, Miyashita M, Matsuo O.

Immun Inflamm Dis. 2016 Aug 2;4(3):338-49. doi: 10.1002/iid3.116. eCollection 2016 Sep.

12.

Plasminogen deficiency is associated with improved glucose tolerance, and lower DPP-4 activity.

Kanno Y, Sakai A, Miyashita M, Tsuchida K, Matsuo O.

Diabetes Res Clin Pract. 2016 Oct;120:190-3. doi: 10.1016/j.diabres.2016.08.007. Epub 2016 Aug 26.

PMID:
27592166
13.

Association of Nonalcoholic Fatty Liver Disease and Venous Thromboembolism in Women With Endometrial Cancer.

Moeini A, Machida H, Takiuchi T, Blake EA, Hom MS, Miki T, Matsuo O, Matsuo K.

Clin Appl Thromb Hemost. 2017 Nov;23(8):1018-1027. doi: 10.1177/1076029616665925. Epub 2016 Aug 31.

PMID:
27582024
14.

uPA Attenuated LPS-induced Inflammatory Osteoclastogenesis through the Plasmin/PAR-1/Ca(2+)/CaMKK/AMPK Axis.

Kanno Y, Ishisaki A, Kawashita E, Kuretake H, Ikeda K, Matsuo O.

Int J Biol Sci. 2016 Jan 1;12(1):63-71. doi: 10.7150/ijbs.12690. eCollection 2016.

15.

Evaluation of antithrombotic effect: Importance of testing components and methodologies.

Yamamoto J, Tamura Y, Ijiri Y, Iwasaki M, Murakami M, Matsuo O.

Drug Discov Ther. 2015 Aug;9(4):258-66. doi: 10.5582/ddt.2015.01043. Review.

16.

α₂-Antiplasmin is involved in bone loss induced by ovariectomy in mice.

Shiomi A, Kawao N, Yano M, Okada K, Tamura Y, Okumoto K, Matsuo O, Akagi M, Kaji H.

Bone. 2015 Oct;79:233-41. doi: 10.1016/j.bone.2015.06.009. Epub 2015 Jun 18.

PMID:
26094563
17.

The Tissue Fibrinolytic System Contributes to the Induction of Macrophage Function and CCL3 during Bone Repair in Mice.

Kawao N, Tamura Y, Horiuchi Y, Okumoto K, Yano M, Okada K, Matsuo O, Kaji H.

PLoS One. 2015 Apr 20;10(4):e0123982. doi: 10.1371/journal.pone.0123982. eCollection 2015.

18.

Role of plasminogen activator inhibitor-1 in glucocorticoid-induced diabetes and osteopenia in mice.

Tamura Y, Kawao N, Yano M, Okada K, Okumoto K, Chiba Y, Matsuo O, Kaji H.

Diabetes. 2015 Jun;64(6):2194-206. doi: 10.2337/db14-1192. Epub 2014 Dec 31.

19.

Tissue plasminogen activator modulates emotion in a social context.

Nakamura K, Takabe A, Shimizu F, Takahashi M, Matsuo O, Mitsui S.

Behav Brain Res. 2015 Mar 15;281:24-31. doi: 10.1016/j.bbr.2014.11.022. Epub 2014 Dec 11.

PMID:
25499620
20.

α2AP mediated myofibroblast formation and the development of renal fibrosis in unilateral ureteral obstruction.

Kanno Y, Kawashita E, Kokado A, Kuretake H, Ikeda K, Okada K, Seishima M, Ueshima S, Matsuo O, Matsuno H.

Sci Rep. 2014 Aug 6;4:5967. doi: 10.1038/srep05967.

Supplemental Content

Loading ...
Support Center